In vivo activation of LAK cells during systemic IL-2 therapy

Eur Cytokine Netw. 1990 Aug-Sep;1(3):185-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Renal Cell / immunology
  • Carcinoma, Renal Cell / therapy*
  • Cells, Cultured
  • Cytotoxicity, Immunologic
  • Humans
  • Immunotherapy
  • Interferon-gamma / pharmacology*
  • Interferon-gamma / therapeutic use
  • Interleukin-2 / pharmacology*
  • Interleukin-2 / therapeutic use
  • Kidney Neoplasms / immunology
  • Kidney Neoplasms / therapy*
  • Killer Cells, Lymphokine-Activated / drug effects*
  • Killer Cells, Lymphokine-Activated / immunology
  • Killer Cells, Natural / drug effects
  • Lymphocyte Activation / drug effects
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology

Substances

  • Interleukin-2
  • Recombinant Proteins
  • Interferon-gamma